Categories: News

Saudi Minister of Industry and Mineral Resources, Bandar bin Ibrahim Alkhorayef, Elected President of the 21st UNIDO General Conference

RIYADH, Saudi Arabia, Nov. 24, 2025 /PRNewswire/ — His Excellency Bandar bin Ibrahim Alkhorayef, Minister of Industry and Mineral Resources, was formally appointed President of the 21st UNIDO General Conference during its opening ceremony in Riyadh. The appointment reflects the Kingdom’s increasingly influential role in directing the global industrial development agenda.

- Advertisement -

The presidency was confirmed through the general conference, demonstrating strong international consensus for Minister Alkhorayef’s leadership. The outgoing president officially recognized the decision, declaring to the conference: “Distinguished delegates, we will now proceed to elect a President for the twenty-first session of the General Conference. I hereby put forward His Excellency Bandar Alkhorayef, Minister of Industry and Mineral Resources of the Kingdom of Saudi Arabia. It is my pleasure to declare His Excellency Minister Alkhorayef elected by affirmation.”

- Advertisement -

Accepting the role, Minister Alkhorayef emphasized the critical importance of partnership and innovation in shaping industry’s future: “I am deeply honored by the confidence placed in me to serve as President of the twenty-first session of the UNIDO General Conference. I accept this responsibility with a firm commitment to strengthening global industrial cooperation, advancing inclusive and sustainable development, and ensuring that our collective work delivers real impact for all Member States. Together, we will build on the momentum of this session and shape a future where industrial progress supports prosperity, resilience, and opportunity across every region.”

- Advertisement -

As President, Minister Alkhorayef is now tasked with steering high-level negotiations to a successful conclusion at GC21 and ensuring the Riyadh Declaration’s objectives are translated into actionable outcomes. His role is to build consensus among Member States on critical issues, from sustainable supply chains to AI governance in industry. This leadership position climaxes with the responsibility to oversee the smooth handover of the presidency at the next General Conference, ensuring the continuity of UNIDO’s strategic agenda beyond the Riyadh session.

- Advertisement -

For more information, please contact:
Ahmed Mansour
M +966 54 186 9849
E ahmed.mansour@omc.com 

- Advertisement -

 

- Advertisement -

Photo – https://mma.prnewswire.com/media/2830434/Ministry_of_Industry_and_Mineral_Resources.jpg

- Advertisement -

 

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/saudi-minister-of-industry-and-mineral-resources-bandar-bin-ibrahim-alkhorayef-elected-president-of-the-21st-unido-general-conference-302624382.html

- Advertisement -

Recent Posts

Crypto News: AlphaPepe Presale Records Surge in Whale Accumulation As Bitcoin Price Prediction Eyes $180,000

MONACO, May 16, 2026 (GLOBE NEWSWIRE) -- Crypto news is turning toward AlphaPepe after the…

5 hours ago

Crypto Market News: AlphaPepe Finalizes Tier-1 Exchange Shortlist as XRP Price Prediction Targets $5.00

MONACO, May 16, 2026 (GLOBE NEWSWIRE) -- Crypto market news is turning toward AlphaPepe after…

5 hours ago

Qoder Version 1.0 Released: Full Automation of Code Generation, Verification & Delivery

SINGAPORE, May 16, 2026 (GLOBE NEWSWIRE) -- Qoder officially releases version 1.0, upgrading from an…

5 hours ago

Ipsen presents first-in-class late-breaking Phase II corabotase data in glabellar lines showing sustained duration of effect reinforced by consistently high patient satisfaction

Patients treated with corabotase showed a rapid onset of action of 0.84 days and peak effect statistically superior to placeboAt Week 24, 60.8% of patients treated with corabotase experienced clinically…

5 hours ago

ImPact Biotech Presents Updated Data from Phase 3 ENLIGHTED Trial of Padeliporfin VTP in LG-UTUC at AUA 2026

– Complete response (CR) observed in 70% (50/72) of evaluable patients with low-grade upper tract…

5 hours ago

Allarity Therapeutics Reports First Quarter 2026 Results and Continued Stenoparib Development in Multiple Cancers

- Stenoparib clinical development continues in relapsed small cell lung cancer and, under FDA Fast…

5 hours ago